Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of silver nanoparticles on the physiology, stress, and mineral uptake of banana cultivars <i>in vitro</i> and greenhouse.

Frontiers in plant science·2025
Same author

Histopathologic findings in uteri and ovaries collected from clinically healthy dogs at elective ovariohysterectomy: a cross-sectional study.

Journal of veterinary science·2016
Same author

Mapping regions in Ste5 that support Msn5-dependent and -independent nuclear export.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2016
Same author

Mucocutaneous manifestations of helminth infections: Nematodes.

Journal of the American Academy of Dermatology·2015
Same author

Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial.

The American journal of clinical nutrition·2015
Same author

Distinctive cutaneous findings due to a rare complication from a warming device.

Journal of the American Academy of Dermatology·2014

Related Experiment Video

Updated: Jun 24, 2026

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Human papillomavirus vaccines.

Anita Satyaprakash1, Rosella Creed, Parisa Ravanfar

  • 1Center for Clinical Studies, Houston, Texas, USA. asatyaprakash@ccstexas.com

Dermatologic Therapy
|April 2, 2009
PubMed
Summary
This summary is machine-generated.

Human papillomavirus (HPV) vaccines are highly effective in preventing HPV-linked cancers. Recent research advances in both prophylactic and therapeutic HPV vaccines are discussed, offering new hope for disease prevention and treatment.

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Related Experiment Videos

Last Updated: Jun 24, 2026

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Cervical and other cancers are significantly linked to human papillomavirus (HPV) infection, causing substantial morbidity and mortality.
  • The discovery of HPV's etiological role in these cancers has spurred extensive research and development in HPV vaccination strategies.

Purpose of the Study:

  • To review the current landscape of HPV vaccination.
  • To discuss recent advancements in both prophylactic and therapeutic HPV vaccines.

Main Methods:

  • Literature review of existing prophylactic and therapeutic HPV vaccines.
  • Analysis of research and development in the field of HPV vaccination.

Main Results:

  • Current prophylactic HPV vaccines demonstrate high efficacy in preventing diseases caused by specific vaccine types.
  • Recent scientific progress has been made in the development of novel prophylactic and therapeutic vaccines.

Conclusions:

  • HPV vaccination remains a critical tool in preventing HPV-related cancers.
  • Ongoing advancements in vaccine technology promise improved strategies for disease control and potential treatment options.